| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/04/2022 | Citius Pharmaceuticals, Inc. | CTXR | Grant | | 550k | $1.25 | $687.5k | | 10/04/2022 |
| 03/21/2022 | Hillstream BioPharma Inc. | | Grant | Options (right to buy) | 50k | $1.33 | $66.5k | | 03/21/2022 |
| 01/14/2022 | Hillstream BioPharma Inc. | | Conversion | Common Stock | 98.7k | $3.20 | $315.9k | | 01/14/2022 |
| 01/14/2022 | Hillstream BioPharma Inc. | | Purchase | Common Stock | 25k | $4.00 | $100k | | 01/14/2022 |
| 01/14/2022 | Hillstream BioPharma Inc. | | Conversion | Convertible Note | 0 | $3.20 | $0 | | 01/14/2022 |
| 10/11/2021 | Citius Pharmaceuticals, Inc. | CTXR | Grant | | 650k | $2.04 | $1.3M | | 10/11/2021 |
| 07/22/2021 | Citius Pharmaceuticals, Inc. | CTXR | Grant | | 300k | $2.00 | $600k | | 07/22/2021 |
| 10/06/2020 | Citius Pharmaceuticals, Inc. | CTXR | Grant | | 200k | $1.01 | $202k | | 10/06/2020 |
| 10/08/2019 | Citius Pharmaceuticals, Inc. | CTXR | Grant | Options to Purchase Common Stock | 175k | $0.67 | $117.2k | | 10/08/2019 |
| 09/27/2019 | Citius Pharmaceuticals, Inc. | CTXR | Purchase | Common Stock | 2.2M | $0.90 | $2M | | 09/27/2019 |
| 09/27/2019 | Citius Pharmaceuticals, Inc. | CTXR | Purchase | | 2.2M | $0.77 | $1.7M | | 09/27/2019 |
| 04/03/2019 | Citius Pharmaceuticals, Inc. | CTXR | Purchase | | 1.2M | $1.42 | $1.7M | | 04/03/2019 |
| 04/03/2019 | Citius Pharmaceuticals, Inc. | CTXR | Purchase | Common Stock | 1.2M | $1.55 | $1.8M | | 04/03/2019 |
| 09/04/2018 | Citius Pharmaceuticals, Inc. | CTXR | Grant | | 150k | $1.62 | $243k | | 09/04/2018 |
| 08/13/2018 | Citius Pharmaceuticals, Inc. | CTXR | Purchase | Common Stock | 3.1M | $1.28 | $4M | | 08/13/2018 |
| 08/13/2018 | Citius Pharmaceuticals, Inc. | CTXR | Grant | | 3.1M | $1.15 | $3.6M | | 08/13/2018 |
| 03/29/2018 | Citius Pharmaceuticals, Inc. | CTXR | Purchase | Common Stock | 167.5k | $2.99 | $500k | | 03/29/2018 |
| 03/29/2018 | Citius Pharmaceuticals, Inc. | CTXR | Purchase | | 167.5k | $2.86 | $479.1k | | 03/29/2018 |
| 12/19/2017 | Citius Pharmaceuticals, Inc. | CTXR | Purchase | Common Stock | 213.1k | $4.69 | $999.5k | | 12/19/2017 |
| 09/15/2017 | Citius Pharmaceuticals, Inc. | CTXR | Grant | | 40k | $3.45 | $138k | | 09/15/2017 |
| 08/24/2017 | Citius Pharmaceuticals, Inc. | CTXR | Purchase | | 11k | $4.13 | $45.4k | | 08/24/2017 |
| 08/24/2017 | Citius Pharmaceuticals, Inc. | CTXR | Purchase | Common Stock | 11k | $2.68 | $29.5k | | 08/24/2017 |
| 08/08/2017 | Citius Pharmaceuticals, Inc. | CTXR | Conversion | | 1.5M | $3.09 | $4.8M | | 08/08/2017 |
| 08/08/2017 | Citius Pharmaceuticals, Inc. | CTXR | Grant | | 1.5M | $3.09 | $4.8M | | 08/08/2017 |
| 08/08/2017 | Citius Pharmaceuticals, Inc. | CTXR | Purchase | | 421.4k | $4.13 | $1.7M | | 08/08/2017 |
| 08/08/2017 | Citius Pharmaceuticals, Inc. | CTXR | Conversion | Common Stock | 1.5M | $3.09 | $4.8M | | 08/08/2017 |
| 08/08/2017 | Citius Pharmaceuticals, Inc. | CTXR | Purchase | Common Stock | 421.4k | $4.13 | $1.7M | | 08/08/2017 |
| 03/30/2016 | Citius Pharmaceuticals, Inc. | CTXR | Other (acquisition) | Warrant to Purchase Common Stock | 0 | $0.00 | $0 | | 03/30/2016 |
| 03/30/2016 | Citius Pharmaceuticals, Inc. | CTXR | Other (acquisition) | Common Stock | 15.1M | $0.00 | $0 | | 03/30/2016 |
| 03/30/2016 | Citius Pharmaceuticals, Inc. | CTXR | Purchase | Common Stock | 5M | $0.60 | $3M | | 03/30/2016 |
| 01/03/2011 | Gadsden Properties, Inc. | FCRE | Grant | PhotoMedex Restricted Stock | 1000 | $5.95 | $6k | | 01/03/2011 |
| 12/08/2010 | Gadsden Properties, Inc. | FCRE | Grant | Common Stock | 5.4k | $5.75 | $31.2k | | 12/08/2010 |
| 01/01/2010 | Gadsden Properties, Inc. | FCRE | Grant | Non-Qualified Stock Options | 5k | $0.95 | $4.8k | | 01/01/2010 |